Home/Hedge Fund Intelligence/Cullinan Therapeutics, Inc.
Nasdaq: CGEMStockForm 13F30 Jun 2026

Hedge funds that hold Cullinan Therapeutics, Inc. Nasdaq: CGEM

CUSIP 230031106 · who reports it, how much, and how much it matters to them

25 of the 720 hedge fund managers we track reported shares of Cullinan Therapeutics, Inc. (Nasdaq: CGEM) on Form 13F for 30 June 2026. Between them they reported USD 198m. The largest position belongs to Kynam Capital Management, at USD 57m.

Managers reporting it25of 720 we track
Value they reportUSD 198mshares only, 30 Jun 2026
Funds they run261with a file on PPLI.com
Largest positionUSD 57mKynam Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight3.1%Kynam Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

25 managers, USD 198m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Cullinan Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Kynam Capital Management1 fund on PPLI.comUSD 57m3.1%
2RTW Investments2 funds on PPLI.comUSD 43m0.4%
3Boothbay Fund Management2 funds on PPLI.comUSD 20m0.3%
4Boone Capital Management1 fund on PPLI.comUSD 13m3.0%
5Perceptive Advisors6 funds on PPLI.comUSD 7.8m0.1%
6Citadel Advisors32 funds on PPLI.comUSD 7.2m0.0%
7Millennium Management6 funds on PPLI.comUSD 6.3m0.0%
8Renaissance Technologies13 funds on PPLI.comUSD 6m0.0%
9Great Point Partners2 funds on PPLI.comUSD 5.5m1.0%
10Two Sigma Investments35 funds on PPLI.comUSD 5m0.0%
11Bleichroeder4 funds on PPLI.comUSD 4.6m0.8%
12Adage Capital Management1 fund on PPLI.comUSD 4.3m0.0%
13PFM Health Sciences3 funds on PPLI.comUSD 3.5m0.3%
14Moore Capital Management7 funds on PPLI.comUSD 3.5m0.1%
15Squarepoint Ops7 funds on PPLI.comUSD 3.1m0.0%
16Engineers Gate Manager1 fund on PPLI.comUSD 2.8m0.0%
17Apis Capital Advisors4 funds on PPLI.comUSD 1.5m0.1%
18POINT72 Asset Management17 funds on PPLI.comUSD 1.4m0.0%
19Marshall Wace LLP84 funds on PPLI.comUSD 1.2m0.0%
20Verdad Advisers6 funds on PPLI.comUSD 528,0000.5%
21Exoduspoint Capital Management7 funds on PPLI.comUSD 520,0000.0%
22Tudor Investment Corporation10 funds on PPLI.comUSD 410,0000.0%
23Entrypoint Capital1 fund on PPLI.comUSD 210,0000.1%
24Campbell & Company Investment Adviser8 funds on PPLI.comUSD 202,0000.0%
25The Quarry1 fund on PPLI.comUSD 176,0000.0%
Next: where it matters most
Where it matters most

For Kynam Capital Management it is 3.1% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kynam Capital ManagementUSD 57m3.1%
2Boone Capital ManagementUSD 13m3.0%
3Great Point PartnersUSD 5.5m1.0%
4BleichroederUSD 4.6m0.8%
5Verdad AdvisersUSD 528,0000.5%
6RTW InvestmentsUSD 43m0.4%
7PFM Health SciencesUSD 3.5m0.3%
8Boothbay Fund ManagementUSD 20m0.3%
9Apis Capital AdvisorsUSD 1.5m0.1%
10Perceptive AdvisorsUSD 7.8m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Cullinan Therapeutics, Inc.

What is the ticker symbol of Cullinan Therapeutics, Inc.?

Cullinan Therapeutics, Inc. trades under the symbol CGEM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 230031106.

Which hedge funds own Cullinan Therapeutics, Inc. (Nasdaq: CGEM)?

25 of the 720 hedge fund managers PPLI.com tracks reported Cullinan Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Kynam Capital Management (USD 57m), RTW Investments (USD 43m), Boothbay Fund Management (USD 20m), Boone Capital Management (USD 13m) and Perceptive Advisors (USD 7.8m).

How many hedge funds hold Cullinan Therapeutics, Inc.?

25 managers in our coverage reported it, and between them they run 261 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Cullinan Therapeutics, Inc.?

Kynam Capital Management, where the position was 3.1% of the reported 13F book at 30 June 2026.

Does this show who is short Cullinan Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Cullinan Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.